Back to Clinical Trials Overview

Your search for "Gastroenterology" returned 22 results:


A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

A Phase 2, randomized, placebo-controlled, multicenter study to investigate the efficacy and safety of GED-0507-34-Levo (GED0507) for treatment of subjects with active ulcerative colitis
Principal Investigator(s): James Marion

A Multicenter, Open-Label Study to Evaluate the Long Term Efficacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease
Principal Investigator(s): James Marion

A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects with Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis
Principal Investigator(s): Ioannis Oikonomou

A Randomized, Double-Blind, Multicenter Study to Explore The Effect Of GED-0301 on Endoscopic and Clinical Outcomes in Subjects with Active Crohn's Disease
Principal Investigator(s): Bruce Sands

An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Triple Combination Therapy with Vedolizumab IV, Adalimumab SC, and Oral Methotrexate in Early Treatment of Subjects with Crohn's Disease Stratified at Higher Risk for Developing Complications
Principal Investigator(s): James Marion

A Multicenter Randomized Double-Blind Study to Evaluate the Efficacy and Safety of Two Adalimumab Induction Regiments in Subjects with Moderately Severely Active Crohn's Disease and Evidence of Mucosal Ulceration
Principal Investigator(s): James Marion

A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects with Crohn’s Disease
Principal Investigator(s): Bruce Sands

Bacterial Transmission In Utero and IBD Risk: The MECONIUM Study
Principal Investigator(s): Inga Peter

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Oral RPC1063 as Induction and Maintenance Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator(s): Jean-Frederic Colombel

A multi-center, open-label study of CP-690,550 in subjects with moderate to severe ulcerative colitis (A3921139)
Principal Investigator(s): James Marion

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis
Principal Investigator(s): Chehade, Mirna

Food Protein-Induced Enterocolitis Syndrome - FPIES (ages 6 months-21 years)
Principal Investigator(s): Nowak-Wegrzyn, Anna

Entyvio (vedolizumab) long-term safety study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn's Disease. [MLN-0002_401]
Principal Investigator(s): James Marion

A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of Mongersen (GED-0301) for the treatment of subjects with active Crohn’s disease
Principal Investigator(s): Bruce Sands

A Multicenter Long-term Extension Study to Further Evaluate the Safety and Tolerability of Telotristat Etiprate (LX1606)
Principal Investigator(s): Michelle Kim

A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects With Ulcerative Colitis
Principal Investigator(s): Bruce Sands

A Phase 3 Prospective, Randomized, Double-Blind, Multi-Center, Phase 2 Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo for Tumor Control in Patients with well Differentiated, Advanced Lung or Thymus Neuroendocrine Tumors (SPINET)
Principal Investigator(s): Michelle Kim

Integrative approaches to managing Irritable Bowel Syndrome (IBS)
Principal Investigator(s): Elizabeth McDonald, MS, RDN, CSSD and Benjamin Kligler, MD, MPH

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection study In Crohn's disease patients (MOBIDIC)
Principal Investigator(s): Jean-Frederic Colombel

A Double-Blind Randomized Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Principal Investigator(s): James Marion

A 24- Week Study of the Efficacy and Safety of Teduglutide in Subjects with Parental Nutrition-Dependent Short Bowel Syndrome CL0600-020
Principal Investigator(s): Iyer, Kishore